SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection

The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection.

source https://www.sciencedaily.com/releases/2021/07/210701120701.htm